Overall, this study provides novel insights on identifying the downstream effectors of LSD1 in PCa cells and the study will have a strong translational impact as it indicates that the LSD1 inhibitor treatment may be effective in delaying the progression of CRPC as it targets both AR signaling and PI3K/AKT signaling pathways. This evidence concerns the gene AKT1 and posterior cortical atrophy.